Spie SA (0R8M)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 42.29 |
|---|---|
| 52-week range | 40.50 – 53.35 |
| Return, 1 month / 3 months | −1.7% / −13.2% |
| Return, 1 year / 3 years | −8.8% / +86.2% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 27.5% |
| Worst drawdown (1 year) | -22.6% |
| Average daily value traded | 8.88M EUR |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Spie SA is a French company that provides multi-technical services in energy and mechanical and electrical engineering. It designs, installs and maintains systems for buildings, industrial facilities and infrastructure, working with clients in sectors such as energy, manufacturing, transport and the public sector. The company is based in France and operates through local branches that serve customers in several European countries, helping them with electrical, heating, cooling and communication systems.
On this site Spie SA appears as a stock on the London Stock Exchange (UK), code 0R8M, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Spie SA (0R8M) trades on the London Stock Exchange in UK. It last closed at EUR 42.29 on 27 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 2,232 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.8% and over the last three months it fell 13.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 33 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.8% | ||
| From 52-week high | -19.9% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -13.2% | ||
| 6-month return | -12.7% | ||
| 12-month return, skipping the last month | -7.2% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.6% | ||
| Liquidity | 73 · Strong | Trades actively. | |
| Average daily value traded | 8.88M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.7% |
|---|---|
| 1 month | −1.7% |
| 3 months | −13.2% |
| 6 months | −12.7% |
| 1 year | −8.8% |
| 3 years | +86.2% |
| 5 years | +128.7% |
Signals
| 50-day / 200-day average | 43.02 / 46.37 |
|---|---|
| Golden / death cross (60 days) | Death, 36 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.78 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | EUR 0.3200 |
| 11 May 2026 | EUR 0.7800 |
| 16 Sep 2025 | EUR 0.3000 |
| 14 May 2025 | EUR 0.7500 |
| 18 Sep 2024 | EUR 0.2500 |
| 14 May 2024 | EUR 0.6100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.